Page 59 - 86_02
P. 59

ANALES
 RANF

   www.analesranf.com

51. Sharma D, Maheshwari D, Philip G, Rana R, Bhatia S, Singh M, et al.
    Formulation and optimization of polymeric nanoparticles for intranasal
    delivery of lorazepam using Box-Behnken design: in vitro and in vivo
    evaluation. Biomed Res Int. 2014;2014:156010.

52. Jang JH, Jeong SH, Lee YB. Preparation and In Vitro/In Vivo Charac-
    terization of Polymeric Nanoparticles Containing Methotrexate to Im-
    prove Lymphatic Delivery. Int J Mol Sci. 2019;20(13).

53. Singh R, Kesharwani P, Mehra NK, Singh S, Banerjee S, Jain NK. De-
    velopment and characterization of folate anchored Saquinavir entrap-
    ped PLGA nanoparticles for anti-tumor activity. Drug development and
    industrial pharmacy. 2015;41(11):1888-901.

54. Gupta A, Kaur CD, Saraf S, Saraf S. Formulation, characterization, and
    evaluation of ligand-conjugated biodegradable quercetin nanoparticles
    for active targeting. Artificial cells, nanomedicine, and biotechnology.
    2016;44(3):960-70.

55. Yao S, Li L, Su XT, Wang K, Lu ZJ, Yuan CZ, et al. Development and
    evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers
    for ovarian cancer treatment: in vitro and in vivo. J Exp Clin Cancer
    Res. 2018;37(1):29.

56. Luiz MT, Abriata JP, Raspantini GL, Tofani LB, Fumagalli F, de Melo
    SMG, et al. In vitro evaluation of folate-modified PLGA nanoparticles
    containing paclitaxel for ovarian cancer therapy. Materials science &
    engineering C, Materials for biological applications.
    2019;105:110038.

57. Ak G, Yilmaz H, Gunes A, Hamarat Sanlier S. In vitro and in vivo eva-
    luation of folate receptor-targeted a novel magnetic drug delivery
    system for ovarian cancer therapy. Artificial cells, nanomedicine, and
    biotechnology. 2018;46(sup1):926-37.

 DecLArAcIÓN De trANsPAreNcIA
   Los autores de este manuscrito declaran no tener ningún tipo de
   conflicto de intereses.

                                                    Si desea citar nuestro artículo:
                                         Ana I. Fraguas , Ana I. Torres Suárez, et al
                           Quimioterapia nanométrica a base de cannabinoides
                                    para el tratamiento de tumores ginecológicos

                                                     An Real Acad Farm [Internet].
                            An Real Acad Farm Vol. 86. Nº 2 (2020) · pp. 133-150

                                                                      DOI: http://

                                                                                                   Quimioterapia nanométrica a base de cannabinoides

                                                     149para el tratamiento de tumores ginecológicos
                                                                                                                           Ana I. Fraguas , Ana I. Torres Suárez, et al
                                                                                                                                An Real Acad Farm Vol. 86. Nº 2 (2020) · pp. 133-150
   54   55   56   57   58   59   60   61   62